Kirch W, Hutt H J, Dylewicz P, Gräf K J, Ohnhaus E E
Clin Pharmacol Ther. 1986 Jan;39(1):35-9. doi: 10.1038/clpt.1986.6.
The dose-dependence of the nifedipine-digoxin interaction was investigated in seven healthy subjects. After an adequate loading dose of digoxin for 2 weeks, 0.25 mg digoxin b.i.d. was given by mouth by itself. Afterwards, 0.25 mg digoxin was given twice a day for three 1-week periods in combination with capsules of nifedipine, 5, 10, or 20 mg, respectively, given on a thrice-daily basis. The study ended with a digoxin monotherapy phase lasting 7 days. All three doses of nifedipine significantly increased digoxin plasma concentrations and AUC compared with digoxin monotherapy. Thus, for example, the AUC was 10.16 +/- 0.88 ng/ml . hr (mean +/- SE) when digoxin was given alone and 12.33 +/- 1.59 ng/ml . hr with concurrent nifedipine, 5 mg t.i.d. (P less than 0.05). Nifedipine causes a slight but significant increase (15%) in digoxin plasma concentrations and AUC. This effect did not depend on the nifedipine dose given in the range studied.
在7名健康受试者中研究了硝苯地平与地高辛相互作用的剂量依赖性。在给予地高辛充分的负荷剂量2周后,单独口服0.25mg地高辛,每日2次。之后,在三个为期1周的时间段内,每日2次给予0.25mg地高辛,并分别联合每日3次给予5mg、10mg或20mg的硝苯地平胶囊。研究以持续7天的地高辛单一疗法阶段结束。与地高辛单一疗法相比,所有三种剂量的硝苯地平均显著提高了地高辛的血浆浓度和AUC。例如,单独给予地高辛时,AUC为10.16±0.88ng/ml·小时(平均值±标准误),同时给予5mg每日3次的硝苯地平时,AUC为12.33±1.59ng/ml·小时(P<0.05)。硝苯地平使地高辛的血浆浓度和AUC略有但显著增加(15%)。在所研究的剂量范围内,这种效应不依赖于硝苯地平的剂量。